Teton Advisors Inc. Sells 12,340 Shares of Neogen Co. (NASDAQ:NEOG)

Teton Advisors Inc. decreased its holdings in shares of Neogen Co. (NASDAQ:NEOG) by 5.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 199,660 shares of the company’s stock after selling 12,340 shares during the period. Neogen makes up 1.3% of Teton Advisors Inc.’s holdings, making the stock its 18th largest position. Teton Advisors Inc. owned 0.09% of Neogen worth $4,015,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. ACK Asset Management LLC lifted its stake in Neogen by 3.0% in the fourth quarter. ACK Asset Management LLC now owns 2,059,400 shares of the company’s stock valued at $41,415,000 after buying an additional 59,400 shares during the period. Nicholas Company Inc. boosted its stake in Neogen by 65.2% during the 4th quarter. Nicholas Company Inc. now owns 320,067 shares of the company’s stock worth $6,437,000 after acquiring an additional 126,275 shares during the last quarter. Alberta Investment Management Corp grew its holdings in Neogen by 21.3% during the fourth quarter. Alberta Investment Management Corp now owns 87,884 shares of the company’s stock valued at $1,767,000 after purchasing an additional 15,460 shares during the period. Evoke Wealth LLC bought a new stake in Neogen in the fourth quarter valued at approximately $1,680,000. Finally, Legacy Advisors LLC increased its stake in Neogen by 83.7% in the fourth quarter. Legacy Advisors LLC now owns 25,388 shares of the company’s stock valued at $511,000 after purchasing an additional 11,571 shares in the last quarter. Institutional investors and hedge funds own 96.73% of the company’s stock.

Analysts Set New Price Targets

Separately, Piper Sandler decreased their price target on shares of Neogen from $19.00 to $17.00 and set a “neutral” rating for the company in a report on Monday, April 15th.

Neogen Stock Up 2.3 %

Shares of NEOG traded up $0.28 on Monday, hitting $12.42. The company’s stock had a trading volume of 1,911,738 shares, compared to its average volume of 2,138,015. The firm’s fifty day moving average price is $14.81 and its 200-day moving average price is $16.32. Neogen Co. has a fifty-two week low of $11.46 and a fifty-two week high of $24.09. The company has a quick ratio of 2.66, a current ratio of 3.82 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $2.69 billion, a price-to-earnings ratio of 1,243.24 and a beta of 1.13.

Neogen (NASDAQ:NEOG) last released its quarterly earnings results on Tuesday, April 9th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.02). Neogen had a net margin of 0.17% and a return on equity of 3.35%. The company had revenue of $228.80 million during the quarter, compared to analyst estimates of $230.01 million. During the same quarter last year, the company earned $0.12 EPS. The firm’s quarterly revenue was up 4.8% compared to the same quarter last year. On average, equities research analysts expect that Neogen Co. will post 0.5 EPS for the current year.

Insider Buying and Selling

In other news, CEO John Edward Adent purchased 23,000 shares of the company’s stock in a transaction on Wednesday, April 10th. The shares were purchased at an average price of $12.36 per share, with a total value of $284,280.00. Following the purchase, the chief executive officer now directly owns 152,389 shares of the company’s stock, valued at approximately $1,883,528.04. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Neogen news, CEO John Edward Adent purchased 23,000 shares of the firm’s stock in a transaction dated Wednesday, April 10th. The stock was bought at an average cost of $12.36 per share, with a total value of $284,280.00. Following the purchase, the chief executive officer now directly owns 152,389 shares of the company’s stock, valued at $1,883,528.04. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director James C. Borel purchased 7,500 shares of the business’s stock in a transaction on Thursday, April 11th. The shares were acquired at an average cost of $13.06 per share, for a total transaction of $97,950.00. Following the completion of the transaction, the director now directly owns 21,392 shares in the company, valued at $279,379.52. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 53,000 shares of company stock valued at $662,205. Company insiders own 0.71% of the company’s stock.

Neogen Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.